BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Jemincare declared Ph I trial of its anti-SARS-CoV-2 neutralizing antibody

The clinical trial of JMB2002 was stated in January 2021. A single-center, randomized, double-blind, placebo-controlled, single-dose escalation phas...

September 14, 2021 | News

NeuExcell to reach the full potential of their innovative gene technology platform on accelerated timelines

FUJIFILM Diosynth Biotechnologies (FDB) will provide essential drug substance and drug product manufacturing, under accelerated timelines, for NeuExcell'...

September 13, 2021 | News

Odyssey Group Approved to Start Human Trial to Treat Concussion

The Company’s Clinical Trial Protocol was approved by the Alfred Ethics Committee and allows for the immediate start of the human trial. “We a...

September 08, 2021 | News

WuXi Biologics Received First Manufacturing License from Japan

WuXi Biologics (WuXi Bio) , a global company with leading open-access biologics technology platforms, today announced that it has received the Manufacturin...

September 02, 2021 | News

Antengene & MindRank AI to jointly develop first-in-class small-molecule oncology drugs

Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commerc...

August 09, 2021 | News

Nanoform and Boehringer Ingelheim execute master services agreement

The two parties have executed a master services agreement (MSA) to initiate projects in the pre-clinical early development space with the aim of ...

August 04, 2021 | News

WuXi Biologics Biosafety Testing Facility Received Second EMA GMP Certificate

This additional EMA GMP certificate was issued following a remote inspection conducted by Poland's Chief Pharmaceutical Inspectorate in Apri...

August 03, 2021 | News

Curia to Acquire US-Based LakePharma

Adds integrated biologics development platform from discovery through GMP manufacturing Curia, formerly AMRI, a leading contract research, development and...

July 19, 2021 | News

Toxicology IND Preclinical Research Services by Altogen Labs CRO

Pharmacology and toxicology testing performed both in vitro and in vivo, ensuring safety and effectiveness that is of utmost importance for any novel medic...

July 06, 2021 | News

Kazia Provides Progress Update on Paxalisib and EVT801 Clinical Programs

Key Points GBM AGILE pivotal study of paxalisib is recruiting ahead of expectations, with almost 25 sites now open to the paxalisib arm. Paxalisib phas...

July 01, 2021 | News

Aragen Announces Expansion of Discovery Research Agreement with Boehringer Ingelheim

This preferred partnership allows Boehringer Ingelheim, a leading research driven pharmaceutical company, to incorporate several design elements, synthesiz...

June 30, 2021 | News

Phase III Clinical Trial of BIOKANGTAI COVID-19 Vaccine Initiated in Malaysia

On June 21, local time, phase III clinical fieldwork of the Inactivated COVID-19 Vaccine (Vero cells) independently developed and manufactured by Shen...

June 23, 2021 | News

Medidata to Offer Secure Platform for Decentralization of Clinical Trials

The first company in the world to unify direct patient data capture technology with study oversight and monitoring, Medidata redefines end-to-end...

June 16, 2021 | News

Novavax Announces Positive Data for COVID-19 Beta (B.1.351) Variant Strain Vaccine

Novavax Announces Positive Data from Three Complementary Studies of COVID-19 Beta (B.1.351) Variant Strain Vaccine - Primates boosted with rS-B.1.351 vacc...

June 12, 2021 | News

Stay Connected